Medibank Private Past Earnings Performance

Past criteria checks 3/6

Medibank Private's earnings have been declining at an average annual rate of -9.8%, while the Insurance industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 3.3% per year. Medibank Private's return on equity is 21.5%, and it has net margins of 0.05%.

Key information

-9.8%

Earnings growth rate

-6.8%

EPS growth rate

Insurance Industry Growth	5.9%
Revenue growth rate	3.3%
Return on equity	21.5%
Net Margin	0.05%
Last Earnings Update	30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medibank Private makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:MPV Revenue, expenses and earnings (AUD Millions)
Date	Revenue	Earnings	G+A Expenses
30 Jun 24	8,030	4	620
31 Mar 24	7,939	89	610
31 Dec 23	7,944	685	821
30 Sep 23	7,720	598	804
30 Jun 23	7,398	0	567
31 Mar 23	7,261	171	620
31 Dec 22	7,124	343	674
30 Sep 22	7,114	368	713
30 Jun 22	7,105	394	752
31 Mar 22	7,117	414	738
31 Dec 21	7,130	435	725
30 Sep 21	7,081	438	720
30 Jun 21	7,032	441	716
31 Mar 21	6,930	402	720
31 Dec 20	6,829	363	725
30 Sep 20	6,804	340	718
30 Jun 20	6,779	316	712
31 Mar 20	6,836	368	707
31 Dec 19	6,892	420	701
30 Sep 19	6,829	429	711
30 Jun 19	6,765	438	721
31 Dec 18	6,381	375	501
30 Sep 18	6,479	400	594
30 Jun 18	6,577	424	686
31 Mar 18	7,010	454	1,082
31 Dec 17	7,006	463	1,070
30 Sep 17	6,977	456	1,072
30 Jun 17	6,948	450	1,073
31 Mar 17	6,914	436	1,060
31 Dec 16	6,879	422	1,047
30 Sep 16	6,843	420	1,051
30 Jun 16	6,807	418	1,055
31 Mar 16	6,791	393	1,075
31 Dec 15	6,774	369	1,095
30 Sep 15	6,728	327	1,102
30 Jun 15	6,682	285	1,109
31 Mar 15	6,631	244	1,152
31 Dec 14	6,581	204	1,195
30 Sep 14	6,533	167	1,217
30 Jun 14	6,486	131	1,239

Quality Earnings: MPV has high quality earnings.

Growing Profit Margin: MPV's current net profit margins (0.05%) are higher than last year (0%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MPV's earnings have declined by 9.8% per year over the past 5 years.

Accelerating Growth: Insufficient data to compare MPV's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if MPV's earnings growth over the past year exceeded the Insurance industry average.

Medibank Private Past Earnings Performance

Past criteria checks 3/6

Key information

Recent past performance updates

Full year 2024 earnings released: EPS: AU$0.18 (vs AU$0.19 in FY 2023)

First half 2024 earnings released: EPS: AU$0.13 (vs AU$0.061 in 1H 2023)

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

Full year 2023 earnings released: EPS: AU$0.19 (vs AU$0.14 in FY 2022)

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: EPS: AU$0.085 (vs AU$0.08 in 1H 2022)

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Full year 2024 earnings released: EPS: AU$0.18 (vs AU$0.19 in FY 2023)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 18%

Now 35% undervalued after recent price drop

High number of new directors

First half dividend of AU$0.072 announced

First half 2024 earnings released: EPS: AU$0.13 (vs AU$0.061 in 1H 2023)

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings released: EPS: AU$0.19 (vs AU$0.14 in FY 2022)

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Now 20% undervalued after recent price drop

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: EPS: AU$0.085 (vs AU$0.08 in 1H 2022)

Now 20% undervalued

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Full year 2022 earnings released: EPS: AU$0.14 (vs AU$0.16 in FY 2021)

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought €102k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Upcoming dividend of AU$0.069 per share

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

Medibank Private Limited Provides Earnings Guidance for 2022

CEO & Director Craig Drummond has left the company

Revenue misses expectations

First half 2021 earnings released: EPS AU$0.082 (vs AU$0.065 in 1H 2020)

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

New 90-day high: €1.88

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: €1.85

New 90-day high: €1.72

Independent Non-Executive Director recently bought €70k worth of stock

New 90-day low - €1.65

Full year earnings released - EPS €0.11

Revenue & Expenses Breakdown

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies